MYLAN 5300 MYLAN 5300 (Nizatidine 300 mg)
This pill with imprint "MYLAN 5300 MYLAN 5300" is Purple, Capsule-shape and has been identified as Nizatidine 300 mg. It is manufactured by Mylan Pharmaceuticals Inc..
Nizatidine is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 5300 MYLAN 5300
- Strength:
- 300 mg
- Color:
- Purple
- Size:
- 17.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5300
- Inactive Ingredients:
- ammonia
lactose anhydrous
silicon dioxide
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
gelatin
isopropyl alcohol
magnesium stearate
butyl alcohol
corn starch
propylene glycol
shellac
dimethicone
sodium lauryl sulfate
titanium dioxide
Note: Inactive ingredients may vary.
More about nizatidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 6 Reviews – Add your own review/rating
- Drug class: H2 antagonists
Consumer resources
Other brands: Axid, Axid AR, Axid Pulvules
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
